Dr. Erica I. Lubetkin is an Associate Medical Professor in the Department of
Community Health and Social Medicine at the CUNY School of Medicine. She earned
a B.S. in Neuroscience from Brown University and an M.D. from the Perelman
School of Medicine at the University of Pennsylvania. She completed her
residency in internal medicine at the New York-Presbyterian Hospital/Weill
Cornell Medical Center and her fellowship in general medicine at
New York-Presbyterian Hospital/Columbia, where she earned an M.P.H. in Health
Policy and management/effectiveness and outcomes. Her research focuses on
measuring health-related quality of life and assessing the burden of disease
due to social determinants of health, behavioral risk factors and chronic
conditions in patients and the general population. She currently serves as the
course director of the M1 and M2 evidence-based Medicine classes. She has
served as the principal investigator or co-investigator in a number of observational
studies and clinical trials, and her work has been funded by NIH/NCI, AHRQ and
the EuroQol Foundation.
Dr. Erica I. Lubetkin is an Associate Medical Professor in the Department of
Community Health and Social Medicine at the CUNY School of Medicine. She earned
a B.S. in Neuroscience from Brown University and an M.D. from the Perelman
School of Medicine at the University of Pennsylvania. She completed her
residency in internal medicine at the New York-Presbyterian Hospital/Weill
Cornell Medical Center and her fellowship in general medicine at
New York-Presbyterian Hospital/Columbia, where she earned an M.P.H. in Health
Policy and management/effectiveness and outcomes. Her research focuses on
measuring health-related quality of life and assessing the burden of disease
due to social determinants of health, behavioral risk factors and chronic
conditions in patients and the general population. She currently serves as the
course director of the M1 and M2 evidence-based Medicine classes. She has
served as the principal investigator or co-investigator in a number of observational
studies and clinical trials, and her work has been funded by NIH/NCI, AHRQ and
the EuroQol Foundation.